Notably, Kaplan-Meier and Cox regression analyses, performed on a cohort of 185 CRC patients from our institute, evidenced that TRF2 is not an independent predictor of recurrence and prognosis for patients affected by this tumor. The gene discussed is TERF2; the disease is neoplasm.